Going Concern (new) — NYSE delisting notice for equity deficiency; must regain compliance by September 2027 or face delisting.
Departure Of Ceo (new) — Entire management team and board replaced in Q1 2026 as part of strategic pivot from biotech to defense.
Departure Of Cfo (new) — Entire management team and board replaced in Q1 2026 as part of strategic pivot from biotech to defense.

NYSE: PHGE BiomX Inc. 8-K

BiomX abandons biotech, pivots to Israeli defense tech amid NYSE delisting risk

Filed May 5, 2026 · Period ending May 5, 2026 · ~1 min read

5 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade PHGE commission-free

Open an account, get a free stock.

Investing involves risk. Free stock terms apply.

Generated by AI · Jun 2, 2026 4:38 AM